| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.13B | 43.99B | 42.61B | 41.37B | 28.84B | 15.60B |
| Gross Profit | 8.25B | 8.40B | 8.73B | 10.26B | 8.86B | 5.30B |
| EBITDA | 4.02B | 4.61B | 3.24B | 5.57B | 7.00B | 3.53B |
| Net Income | 1.36B | 1.81B | 292.33M | 1.94B | 4.03B | 2.69B |
Balance Sheet | ||||||
| Total Assets | 71.16B | 71.25B | 69.24B | 70.08B | 66.81B | 31.20B |
| Cash, Cash Equivalents and Short-Term Investments | 14.78B | 18.24B | 13.75B | 12.08B | 15.27B | 17.91B |
| Total Debt | 2.46B | 2.80B | 3.09B | 4.52B | 6.33B | 3.92B |
| Total Liabilities | 32.12B | 32.18B | 30.46B | 30.17B | 28.44B | 15.04B |
| Stockholders Equity | 36.62B | 36.62B | 36.16B | 37.46B | 36.19B | 14.57B |
Cash Flow | ||||||
| Free Cash Flow | 2.07B | 3.26B | 3.67B | 2.43B | 2.81B | 3.27B |
| Operating Cash Flow | 2.73B | 3.87B | 4.61B | 3.32B | 3.41B | 3.61B |
| Investing Cash Flow | -2.39B | 1.69B | -354.10M | 755.46M | -25.09B | -4.63B |
| Financing Cash Flow | -2.59B | -2.82B | -2.79B | -4.41B | 18.30B | 9.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.06B | 6.11 | 15.06% | 4.43% | 4.84% | 4.54% | |
71 Outperform | HK$14.00B | 15.46 | 11.18% | 2.78% | 6.95% | 28.21% | |
69 Neutral | HK$13.04B | 10.01 | 23.68% | 3.82% | 6.94% | -9.60% | |
66 Neutral | HK$19.90B | 30.82 | 1.68% | 4.94% | 9.98% | -68.38% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$14.59B | 11.52 | 74.40% | ― | 6.46% | -3.32% | |
61 Neutral | HK$19.72B | 28.27 | 4.63% | 1.77% | 2.94% | -39.39% |